Tokyo, Japan. / Redwood City, CA — ThinkCyte today announced the successful completion of its Series C funding round. Including the equity financing secured last November, the company raised an additional $15 million in the extension round, bringing the total to $32 million. The extension round was led by Japan Green Investment Corp. for Carbon Neutrality […]
Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma research The NULISAseq™ CNS Disease and Inflammation panels are now available for customers as a contract research service from Biognosys’ high-end proteomics facility in Europe By offering the combination of NULISA affinity-based assays and TrueDiscovery® mass […]
Munich, DE – Biotech startup IRUBIS, developing a state-of- the – art real – time bioprocess monitoring solution, has successfully closed a pre- series A funding round. The financing round was led by BioProcess360 Partners, with participation from previous investors such as High-Tech Gründerfonds (HTGF), Verve Ventures, Ventura BioMed Investors, RoBet KG as well as […]
BC Platforms, a global leader in real world data, healthcare data management, and analytics, today announces the appointment of a new Chairperson of the Board. Jan Berger is a seasoned executive with deep experience at the intersection of healthcare, life sciences, and information technology. Under her leadership BC Platforms continues to drive growth in the global markets […]
Sensific GmbH, a German leader in advanced optical measurement and automation systems, is pleased to announce a strategic partnership with 微纳立方科技（北京）有限公司 (Microblox), a premier provider of comprehensive microfluidics laboratory solutions in China. This collaboration will see Microblox become the official distributor of Sensific’s innovative microfluidics-based products across the Chinese market. Sensific GmbH is renowned for its pioneering […]
Cygnus’ AccuRes Kits to recover, amplify, & quantify remaining host cell DNA during biologic drug manufacturing to produce safer, more stable vaccines, therapies, and more LELAND, N.C. & SAN DIEGO — Cygnus Technologies (Cygnus), TriLink BioTechnologies (TriLink®), both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to launch Cygnus’ AccuRes™ Host Cell DNA Quantification Kits. Together, the companies have […]
Thomas Unt, the CEO of SmiLe Inject Capital Lund, Sweden – SmiLe Inject Capital, an investment company under the SmiLe Venture Hub umbrella, is investing a total of 9 million SEK (0,8 million euros) in three promising life science startups: Uman Sense, Nygen Analytics, and Aligned Bio. All three companies are members of SmiLe and […]
TruSight Oncology Comprehensive is the first US FDA-approved, distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic claims The 500+ gene biomarker test advances access to localized precision oncology for patients SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Food and Drug Administration (FDA) approval […]
Natick, MA – Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the global launch of oncoReveal™ Nexus, a research-use-only (RUO) next-generation sequencing (NGS) kit designed to enable laboratories with a rapid, targeted solution for solid and hematological malignancies to help accelerate the delivery of targeted therapy. A team at New York’s Memorial Sloan Kettering Cancer […]
QUANTUM-SI ANNOUNCES NEW EXECUTIVE TEAM MEMBERS TO ACCELERATE THE EVOLUTION OF THE COMPANY INTO A LEADING PROTEOMIC TOOL PROVIDER Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Todd Bennett will join QSI as the Company’s new Chief Commercial Officer effective September 17, 2024, John Vieceli, Ph.D. has been named Chief Product Officer […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
